|
 Kun Qian, PhD is a Research Specialist for assay development and high-throughput screening at Chemical Biology Consortium Sweden (CBCS), Karolinska Institute, in Stockholm, Sweden. She obtained her PhD in Pharmaceutical Sciences from the University of Georgia in 2017. From 2018 to 2022, she was a postdoctoral researcher at the Department of Pharmacology and Chemical Biology, Emory University School of Medicine, in Atlanta, Georgia, USA. During this time, Kun has led the effort to co-found ICBS-Emory chapter for postdocs and students, and was actively involved in other trainee chapter activities such as organizing the pre-conference trainee forum. Her past research was focused on identifying small molecule inhibitors for Protein Methyltransferases and Protein-Protein Interactions of novel protein targets in cancer and Alzheimer’s Disease.
|
Print Page